Danaher Corp. (DHR) - Net earnings per one share growth for the current year

DHR (Danaher Corporation Inc.) - company brandmark

The investment potential of Danaher Corp. (DHR) is based on a stable B2B stream from pharma giants and research centers. Annual earnings per share growth visualizes this trend, where the value 10.30 describes the current level. Efficiency is confirmed by strict customer lock-in to consumables and acquisition synergies, as well as the creation of a closed instrument ecosystem with high reagent margins.

DHR (Danaher) Net earnings per share growth this year history from 07/04/2022 to 11/17/2026

Financial and market metric breakdowns for Danaher Corporation Inc. (DHR)

- current quotes and average value forecast:
Basic company analysis:Danaher Corp.
Core merchandise of Danaher Corp

To assess the issuer's financial stability, the dynamics of earnings per share are critical, calculated as the percentage deviation of the current EPS from the value of the same period last year. The final annual EPS growth figure confirms the effectiveness of the defensive business model of Danaher Corp. (DHR), where high switching costs in biopharmaceuticals ensure a steady stream of profit, eliminating speculative volatility.

Key competitors

Earnings per share growth this year ISRG|Net earnings per share growth this year BDX|STE (steris.com) - Net earnings per one share growth for the current year|Earnings per share growth in current year West Pharmaceutical Services, Inc. (WST)|BAX (Baxter Corp) - Earnings per share increase in current year|Earnings per share growth in current year Masimo Personal Health MASI|Earnings per share increase in current year STVN|TFX - Earnings per share growth in current year|MMSI - Earnings growth in current year|Envista Holdings Corporation (NVST) - Earnings per share growth in current year|Net earnings per share growth this year ICU Medical|XRAY (dentsplysirona.com) - Earnings growth in current year|Earnings per share growth rate in current year LeMaitre Corp LMAT|Earnings per share growth in current year AtriCure (ATRC)|STAAR Surgical - Earnings per share growth this year|Chromadex Corp - Net earnings per share growth this year|Net earnings per one share growth for the current year ZIMV (ZimVie Inc)|ANGO - Earnings per share growth in current year|Expected net earnings per share growth this year Cerus Corp CERS|TKNO: Earnings growth in current year|Net earnings per share growth this year monogramorthopedics.com|STSS (sharpstechnology.com) - Earnings growth in current year|Earnings per share growth this year INFU (InfuSystem Holdings)|Earnings growth in current year UTMD|KRMD (KORU Medical Systems Inc.) - Earnings per share increase in current year|Earnings per share growth in current year Nyxoah SA NYXH|Earnings per share increase in current year MBOT|Pro-Dex Corp - Earnings growth in current year|Earnings per share growth rate in current year Zentek Ltd|ELUT: Earnings growth in current year|MLSS: Net earnings per one share growth for the current year|Net earnings per share growth this year NXGL|Earnings growth in current year Retractable Technologies|Net earnings per share growth this year HBIO (Harvard Bioscience)|FEMY (Femasys) - Earnings per share increase in current year|Earnings growth in current year MHUA (meihuamed.com)|Predictive Oncology Corp - Earnings per share growth in current year|callanjmb.com - Earnings growth in current year|Earnings per share increase in current year ATRI (atrioncorp.com)|NURO (NeuroMetrix Corp) - Net earnings per share growth this year